Timely and active treatment for bloodstream infections caused by carbapenemase-producing Enterobacteriaceae (CPE) is associated with lower mortality risk, according to a recent study. Moreover, only patients with a high risk of death appear to benefit from combination therapy.
A survey conducted among inpatients in Singapore has implied a high prevalence of healthcare-associated infections (HAIs) and antimicrobial use in acute-care hospitals, according to a recent study.
Individuals with a Clostridium difficile (C. difficile) infection have a high risk of all-cause mortality and recurrence is common in those who survive, according to a study presented at ECCMID 2017*.
The rise of anti-malarial resistant Plasmodium falciparum in areas where malaria is endemic, such as Southeast Asia, calls for the safe and right use of current antimalarials.
Renal transplant recipients have a high incidence of hospitalization due to pyelonephritis, according to a Danish population-based cohort study.
The use of statins is associated with a lower risk of pyogenic liver abscess, according to a Taiwan population-based case-control study.
Individuals with hepatitis C virus (HCV) infection who achieve a sustained virological response (SVR) have improved liver stiffness and a lower risk of hepatocellular carcinoma (HCC), according to a presentation at the Asian Pacific Association for the Study of the Liver annual meeting (APASL 2017) in Shanghai, China.